Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Event Details


Lugano 2014 Criteria for Assessing FDG-PET/CT in Lymphoma

Add this event to your calendar: iCal   Google Calendar

Who should attend?

Clinical Project Management Clinical Trial Study/Protocol Managers Medical Monitors Radiologists Imaging Leads Biostatisticians Medical Oncologists


This webinar will explore:

  • Workflow paradigms for implementation of the Lugano 2014 assessment in oncology trials
  • Evolving issues regarding the use of immunoncologic drugs and their effect on the individual patient images and outcome
  • Usage of PET/CT quantitative measurements and the five point scale along with the validations of these approaches to further objectify reader interpretation
  • How to achieve more uniform and consistent multi-time point imaging assessments in lymphoma clinical trials




Andrew Juurinen

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.